Lourdes Gombau, head of the R&D Department, and Maria Riba, Business Development Manager, presented in the UK the last scientific article of the company, shedding light on the topic of compound intestinal toxicity.
On May 15-17, the 22nd Barrier- and Transporter- days took place in Germany. At the event, Jonatan Cucala, R&D researcher at ReadyCell, presented a poster entitled “PreadyTake, an in vitro ready-to-use cell-based model to evaluate potential drug-transporter interactions.”
Our representatives participated in the 18-month meeting of the StretchBio project, held in Freiburg. The meeting was focused on the design and operation of the functional prototype of the sensor.
The Drug Discovery Summit (DDS) includes high-level national and international speakers, interactive roundtables, knowledge-sharing panel sessions, workshops and networking.
Readycell participated in the annual meeting of the StretchBio Project, which was held at the Danmarks Tekniske Universitet (DTU) in Copenhagen.
Our ReadyCell sales representative Carla Sapienza will travel next August 29th, 30th and 31st to Boston to attend the Brain Barriers Summit, an event that aims to join industry experts through a discursive forum and evaluate how neuropharmaceuticals can be targeted.
